[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2019 [#4]

Announcement Date
20-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -480.93%
YoY- -451.37%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 2,787,317 2,931,368 3,279,684 2,820,530 2,806,462 2,775,996 3,144,432 -7.70%
PBT 65,732 90,412 123,520 -191,865 62,145 85,448 120,972 -33.33%
Tax -21,310 -26,368 -33,860 42,418 -23,097 -27,628 -42,380 -36.68%
NP 44,421 64,044 89,660 -149,447 39,048 57,820 78,592 -31.56%
-
NP to SH 45,093 64,756 89,596 -149,219 39,172 57,796 78,468 -30.80%
-
Tax Rate 32.42% 29.16% 27.41% - 37.17% 32.33% 35.03% -
Total Cost 2,742,896 2,867,324 3,190,024 2,969,977 2,767,414 2,718,176 3,065,840 -7.13%
-
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
Dividend
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Div 34,852 44,409 62,695 22,177 29,557 44,299 62,521 -32.19%
Div Payout % 77.29% 68.58% 69.98% 0.00% 75.46% 76.65% 79.68% -
Equity
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
NOSH 261,705 261,705 261,229 261,229 261,229 261,229 260,505 0.30%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 1.59% 2.18% 2.73% -5.30% 1.39% 2.08% 2.50% -
ROE 13.07% 18.09% 25.60% -44.33% 7.59% 11.15% 14.84% -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 1,066.33 1,122.12 1,255.48 1,081.04 1,076.09 1,065.29 1,207.05 -7.91%
EPS 17.25 24.78 34.28 -57.19 15.01 22.18 30.12 -30.96%
DPS 13.33 17.00 24.00 8.50 11.33 17.00 24.00 -32.35%
NAPS 1.32 1.37 1.34 1.29 1.98 1.99 2.03 -24.88%
Adjusted Per Share Value based on latest NOSH - 261,229
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 193.40 203.39 227.56 195.70 194.73 192.61 218.18 -7.70%
EPS 3.13 4.49 6.22 -10.35 2.72 4.01 5.44 -30.75%
DPS 2.42 3.08 4.35 1.54 2.05 3.07 4.34 -32.18%
NAPS 0.2394 0.2483 0.2429 0.2335 0.3583 0.3598 0.3669 -24.71%
Price Multiplier on Financial Quarter End Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 -
Price 4.32 2.22 1.26 2.06 2.44 2.84 2.27 -
P/RPS 0.41 0.20 0.10 0.19 0.23 0.27 0.19 66.75%
P/EPS 25.04 8.96 3.67 -3.60 16.25 12.80 7.54 122.10%
EY 3.99 11.17 27.22 -27.76 6.16 7.81 13.27 -55.02%
DY 3.09 7.66 19.05 4.13 4.64 5.99 10.57 -55.85%
P/NAPS 3.27 1.62 0.94 1.60 1.23 1.43 1.12 103.87%
Price Multiplier on Announcement Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 -
Price 5.72 4.42 1.88 2.04 2.21 2.66 2.36 -
P/RPS 0.54 0.39 0.15 0.19 0.21 0.25 0.20 93.54%
P/EPS 33.16 17.83 5.48 -3.57 14.71 11.99 7.83 161.07%
EY 3.02 5.61 18.24 -28.04 6.80 8.34 12.76 -61.63%
DY 2.33 3.85 12.77 4.17 5.13 6.39 10.17 -62.45%
P/NAPS 4.33 3.23 1.40 1.58 1.12 1.34 1.16 140.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment